CellaVision AB (publ)

Total Valuation

CellaVision AB (publ) carries a market capitalization of 333.92M, placing it among publicly traded companies globally. Its enterprise value stands at 3.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

CellaVision AB (publ) currently has 23.85M shares outstanding.

Valuation Ratios

CellaVision AB (publ) trades at a trailing price-to-earnings ratio of 25.08.

Enterprise Valuation

On an enterprise value basis, CellaVision AB (publ) trades at an EV/EBITDA multiple of 18.97 and an EV/FCF ratio of 17.87. The EV/Sales ratio of 4.22 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.97 provides insight into valuation relative to core operating earnings.

Financial Position

CellaVision AB (publ) maintains a current ratio of 3.31, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.90, indicating elevated leverage, while an interest coverage ratio of 68.45 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, CellaVision AB (publ) has paid 34.25M in income taxes, reflecting an effective tax rate of 20.97.

Stock Price Statistics

CellaVision AB (publ)'s stock has declined approximately -27.38589% over the past 52 weeks. The 50-day moving average sits at 13.70, while the 200-day moving average is 15.88.

Income Statement

Over the trailing twelve months, CellaVision AB (publ) generated 739.15M in revenue and converted that into 129.09M in net income, yielding earnings per share of 5.41. EBITDA reached 164.34M, while operating income came in at 164.34M.

Balance Sheet

CellaVision AB (publ) holds 172.19M in cash and equivalents against 52.27M in total debt, resulting in a net debt position of -119.91M.

Cash Flow

CellaVision AB (publ) produced 172.59M in operating cash flow over the past twelve months.

Margins

CellaVision AB (publ) operates with a gross margin of 68.71, reflecting its pricing power and cost economics. The operating margin of 22.23 and net profit margin of 17.46 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 50.81 indicates the proportion of earnings distributed to shareholders.

Scores

CellaVision AB (publ) posts an Altman Z-Score of 10.36, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.